| Health / Medical Topics |
MET Tyrosine Kinase Inhibitor BMS-777607
An inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and in tumor angiogenesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
This gene plays a regulatory role in the modulation of cell-surface receptors and hepatocyte growth factor interactions.
A semisynthetic estrogen. Metabolized by the liver to ethynyl estradiol, mestranol serves as the estrogen component in several combination oral contraceptives. …
A type of RNA found in cells. Messenger RNA molecules carry the genetic information needed to make proteins. They carry the…
An official descriptive name of a message.
A usually short communication transmitted by words, signals, or other means from one person, station, or group to another.
A spironolactone derivative and aldosterone antagonist with diuretic activity. Mespirenone, after in vivo metabolization, inhibits aldosterone synthase (steroid 18-hydroxylase), thereby preventing the…
